This inventor holds 1 USPTO granted patent. Top assignees: Institute for Basic Science, Korea Advanced Institute of Science and Technology. Active years: 2026.
Company Filing History:
1 out of 99 
1 out of 2,781 
Years Active: 2026
Title: Myojeong Kim: Innovator in Bioconjugation Technologies
Introduction
Myojeong Kim is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of bioconjugation through his innovative research and development. His work focuses on creating compounds that can selectively bind to specific amino acids, which has important implications in various scientific applications.
Latest Patents
Myojeong Kim holds a patent for a quinolinone derivative compound that selectively binds to cysteine. This patent, titled "Quinolinone derivative compound selectively binding to cysteine, peptide conjugate thereof, and antibody-drug conjugate comprising same," describes a method for forming a conjugate with high chemoselectivity and yield through a radical pathway induced by visible light. This innovative approach can be applied in various ways to enhance bioconjugation techniques.
Career Highlights
Throughout his career, Myojeong Kim has worked with esteemed institutions such as the Institute for Basic Science and the Korea Advanced Institute of Science and Technology. His research has garnered attention for its potential applications in drug development and therapeutic interventions.
Collaborations
Myojeong Kim has collaborated with notable colleagues, including Sungwoo Hong and Jaebong Jang. These partnerships have contributed to the advancement of his research and the successful development of innovative bioconjugation methods.
Conclusion
Myojeong Kim is a key figure in the field of bioconjugation, with a focus on developing compounds that enhance selective binding to amino acids. His contributions through patents and collaborations highlight his commitment to advancing scientific knowledge and technology.